IFN-γ-inducible protein of 10 kDa upregulates the effector functions of eosinophils through β2 integrin and CXCR3 by Takaku, Yotaro et al.
RESEARCH Open Access
IFN-g-inducible protein of 10 kDa upregulates the
effector functions of eosinophils through b2
integrin and CXCR3
Yotaro Takaku
1,2, Kazuyuki Nakagome
1,2*, Takehito Kobayashi
1,2, Koichi Hagiwara
1, Minoru Kanazawa
1 and
Makoto Nagata
1,2
Abstract
Background: Eosinophils play an important role in the pathogenesis of bronchial asthma and its exacerbation.
Recent reports suggest the involvement of IFN-g-inducible protein of 10 kDa (IP-10) in virus-induced asthma
exacerbation. The objective of this study was to examine whether CXCR3 ligands including IP-10 modify the
effector functions of eosinophils.
Methods: Eosinophils isolated from the blood of healthy donors were stimulated with CXCR3 ligands and their
adhesion to rh-ICAM-1 was then measured using eosinophil peroxidase assays. The generation of eosinophil
superoxide anion (O2
-) was examined based on the superoxide dismutase-inhibitable reduction of cytochrome C.
Eosinophil-derived neurotoxin (EDN) release was evaluated to determine whether CXCR3 ligands induced
eosinophil degranulation. Cytokine and chemokine production by eosinophils was examined using a Bio-plex assay.
Results: Eosinophil adhesion to ICAM-1 was significantly enhanced by IP-10, which also significantly induced
eosinophil O2
- generation in the presence of ICAM-1. Both the enhanced adhesion and O2
- generation were
inhibited by an anti-b2 integrin mAb or an anti-CXCR3 mAb. Other CXCR3 ligands, such as monokine induced by
IFN-g (Mig) and IFN-inducible T cell a chemoattractant (I-TAC), also induced eosinophil adhesion and O2
-
generation in the presence of ICAM-1. IP-10, but not Mig or I-TAC, increased the release of EDN. IP-10 increased
the production of a number of cytokines and chemokines by eosinophils.
Conclusions: These findings suggest that CXCR3 ligands such as IP-10 can directly upregulate the effector
functions of eosinophils. These effects might be involved in the activation and infiltration of eosinophils in the
airway of asthma, especially in virus-induced asthma exacerbation.
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Background
Bronchial asthma is a chronic disorder characterized by
airway inflammation, reversible airway obstruction,
mucus hypersecretion, and airway hyperresponsiveness
[1]. A variety of cells, including eosinophils, T lympho-
cytes, mast cells, neutrophils, and dendritic cells, are
involved in the process of airway inflammation of
asthma. Of these cells, eosinophils preferentially accu-
mulate at sites of allergic inflammation and are believed
to play important roles in the pathophysiology of asthma
through the release of a variety of inflammatory media-
tors, including major basic protein, cysteinyl leuko-
trienes (cysLTs), reactive oxygen species and cytokines
[2,3]. Green et al. reported that a treatment strategy
directed at normalization of the induced sputum eosino-
phil count reduces asthma exacerbations [4], suggesting
an important role for eosinophils in the pathogenesis of
asthma exacerbation.
Acute respiratory infections are a major cause of
asthma exacerbation [5,6]. Clinical data suggest that not
only the numbers of neutrophils, but also that of eosino-
phils increases in asthmatic airways during, or following,
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infection increases eosinophil counts in the epithelium
of patients with allergic asthma [7]. The sputum of asth-
matic patients with confirmed viral infection contains
high levels of eosinophilic cationic protein [8]. These
findings suggest that eosinophils are indeed activated
and infiltrate asthmatic airways during or following viral
infection.
The initial steps of eosinophil accumulation in the
asthmatic airway are adhesion to and subsequent migra-
tion across endothelial cells. Eosinophil adhesion mole-
cules, such as a4 integrins including a4b1 (VLA-4,
CD49d/CD29) and b2 integrins including aLb2 (LFA-1,
CD11a/CD18) and aMb2 (Mac-1, CD11b/CD18), play
roles in the adhesion to and transmigration through the
endothelium [10]. Furthermore, eosinophil adhesion to
adhesion molecules, such as vascular cell adhesion
molecule (VCAM)-1 (a ligand for a4 integrins) and
intercellular adhesion molecule (ICAM)-1 (a ligand for
b2 integrins) may augment eosinophil function [11-13].
For example, the adhesion of eosinophils to VCAM-1
stimulates eosinophil superoxide anion (O2
-) generation
[11]. Similarly, adhesion of eosinophils to ICAM-1 aug-
ments both leukotriene (LT) C4 generation and the
release of eosinophil-derived neurotoxin (EDN) [12].
Therefore, interaction between eosinophils and adhesion
molecules would contribute to the development of air-
way inflammation in bronchial asthma.
IFN-g-inducible protein of 10 kDa (IP-10) belongs to
the CXC chemokine subfamily that binds to the com-
mon receptor, CXCR3, and it is produced by various
cell types in response to IFN-g [14]. CXCR3 is expressed
at high levels on Th0 and Th1 lymphocytes. Jinquan et
al. reported that CXCR3 is also expressed on eosino-
phils [15]. Recently, the role of IP-10 in virus-induced
asthma exacerbation has been highlighted [16-18]. How-
ever, whether IP-10 actually modifies allergic airway
inflammation, including the accumulation or activation
of eosinophils, has not been fully investigated.
Monokine induced by IFN-g (Mig) and IFN-inducible
Tc e l la chemoattractant (I-TAC) are also CXC chemo-
kines [19]. However, the roles of Mig or I-TAC in the
pathogenesis of asthma and their effects on eosinophils
have not been elucidated in detail.
H e r e ,w ee x a m i n e dt h ee f f e c to ft h eC X C R 3l i g a n d s
IP-10, Mig and I-TAC on eosinophil functions such as
their adhesion properties, O2
- generation, EDN release
and cytokine production, in the presence or absence of
adhesion molecules such as ICAM-1.
Methods
Preparation of eosinophils
Eosinophils were isolated from peripheral blood speci-
mens collected from non-atopic healthy donors with a
peripheral blood differential eosinophil count of < 5%.
The numbers of males and females, ranging in age from
24 to 42 years, were comparable among the donors.
Written, informed consent was obtained from each
donor before collecting blood samples. Eosinophils were
isolated by negative selection using immunomagnetic
beads as described [11-13,20-23]. Over 98% of the cells
were eosinophils, as determined by morphologic criteria
using May-Grünwald-Giemsa staining. We also con-
firmed by flow cytometry that over 98% of the cells
were CD16-negative/CD14-negative (data not shown).
Eosinophil viability was > 99%, as determined by Trypan
blue dye exclusion. Eosinophils were resuspended in
Hank’s balanced salt solution (HBSS) supplemented
with gelatin to a final concentration of 0.1% (HBSS/gel).
Eosinophil adhesion assay
Eosinophil adhesion to rh-ICAM-1- or rh-VCAM-1-
coated plates was assessed based on the residual eosino-
phil peroxidase (EPO) activity of adherent eosinophils as
described [11-13,20]. Eosinophils (100 μlo f1×1 0
5
cells/ml in HBSS/gel) were incubated at 37°C for 20 min
in rh-ICAM-1- or rh-VCAM-1-coated plates in the pre-
sence or absence of the CXCR3 ligands IP-10 (R&D Sys-
tems, Minneapolis, MN), Mig (R&D Systems), or I-TAC
(R&D Systems). In selected experiments, eosinophils
were incubated with anti-a4-integrin mAb (3 μg/ml;
clone HP1/2; Cosmo Bio Co. Ltd, Tokyo, Japan), anti-
b2-integrin mAb (3 μg/ml; clone L130; Becton Dickin-
son, Franklin Lakes, NJ), or anti-CXCR3 mAb (3 μg/ml;
clone 49801; R&D Systems, Minneapolis, MN) before
assay. The plates were washed with HBSS and 100 μlo f
HBSS/fetal calf serum (FCS) was then added to the
wells. Standards comprised of 100 μl of serially diluted
cell suspensions (1 × 10
3,3×1 0
3,1×1 0
4,3×1 0
4,a n d
1×1 0
5 cells/ml) were added to empty wells. The EPO
substrate (1 mM o-phenylenediamine, 1 mM H2O2,a n d
0.1% Triton X-100 in Tris buffer, pH 8.0) was then
added to all wells and the plates were incubated for 30
min at room temperature. The reaction was stopped by
adding 50 μlo f4MH 2SO4 and absorbance was mea-
sured at 490 nm. Each experiment was performed in
quadruplicate using eosinophils from a single donor,
and percentage eosinophil adhesion was determined
from mean values that were calculated from log dose-
response curves. Eosinophil viability after incubation
was > 98%, as determined by Trypan blue dye exclusion.
Eosinophil superoxide anion generation
Eosinophil O2
- generation was measured in 96-well
plates (Corning Inc.) as described based on the superox-
ide dismutase (SOD)-inhibitable reduction of cyto-
chrome C [11-13]. We initially added SOD (0.2 mg/ml
in HBSS/gel; 20 μl) to SOD control wells and then
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The eosinophil density was adjusted to 1.25 × 10
6 cells/
ml of HBSS/gel mixed 4:1 with cytochrome C (12 mg/
ml of HBSS/gel), and 100 μlo fe o s i n o p h i ls u s p e n s i o n
was then added to all wells. Immediately after adding
CXCR3 ligand, the absorbance of the cell suspensions in
the wells was measured at 550 nm in an Immuno-Mini
(NJ-2300; Japan Intermed Co., Tokyo, Japan), followed
by repeated measurements over the next 240 min. In
selected experiments, eosinophils were incubated with
anti-b2-integrin mAb (3 μg/ml) or anti-CXCR3 mAb (3
μg/ml) before assay. The plates were incubated in a 5%
CO2 incubator at 37°C between measurements. Each
reaction was evaluated in duplicate against the control
reaction in wells containing 20 μg/ml of SOD. The
results were adjusted for a 1-ml reaction volume, and
O2
- generation was calculated at an extinction coeffi-
cient of 21.1 mM
-1cm
-1, as nanomoles of cytochrome C
reduced per 1.0 × 10
6 cells/ml minus the SOD control
[9-11]. The maximum value during the incubation time
was examined to evaluate the effects of various factors
on eosinophil O2
- generation. Cell viability, determined
by Trypan blue exclusion at the end of each experiment,
remained at 95% after a 240-min incubation with the
activator.
Eosinophil Degranulation
Eosinophils (1 × 10
6 cells/ml) in 96-well plates were
incubated for the 240 min that were required for mea-
surement of O2
- generation, and were then immediately
centrifuged (700 g) at 4°C for 15 min. Recovered cell-
free supernatants were subjected to EDN analysis, as
described previously [21]. Levels of EDN were quantified
using ELISA kits (Medical and Biological Laboratory Co
Ltd, Nagoya, Japan).
Cytokine and chemokine production
Eosinophils (1 × 10
6 cells/ml) were resuspended in
RPMI 1640 containing 10% FCS. Cells were incubated
with CXCR3 ligands in 96-well tissue-culture plates for
24 h at 37°C and 5% CO2 [24]. After culture, the super-
natants were collected, and cytokine and chemokine
concentrations were measured by using Bio-plex assay
kits (Bio-Rad, Mississauga, Canada).
Statistical analysis
Values are expressed as means ± SEM. Two groups
were compared using Student’s t test and more than
two groups were compared using a repeated-measures
analysis of variance (ANOVA) with Tukey’s test of mul-
tiple comparisons. Values of P <0 . 0 5w e r ec o n s i d e r e d
statistically significant.
Results
Effect of IP-10 on eosinophil adhesiveness
We initially examined whether or not IP-10 directly
modifies eosinophil adhesiveness. We found that IP-10
(100 nM) significantly enhanced the adhesiveness of
eosinophils to plastic plates compared with controls
(data not shown), suggesting that IP-10 modifies adhe-
sive interactions between eosinophils and adhesion
molecules. To test this hypothesis, we investigated the
effect of IP-10 on eosinophil adhesion to recombinant
adhesion molecules. Eosinophils were stimulated with
rh-IP-10 (10-100 nM) in the presence of immobilized
rh-ICAM-1 or rh-VCAM-1, and adhesion was then eval-
uated. Under these conditions, IP-10 did not signifi-
cantly increase eosinophil adhesion to ICAM-1 at a
concentration of 10 nM, but did significantly enhance
adhesion to ICAM-1 at a concentration of 30 and 100
nM, compared with the control (14.3 ± 2.5%, 17.6 ±
3.4% and 22.8 ± 5.5% vs. 6.1 ± 1.1%; NS, P < 0.05 and P
< 0.05, respectively; n = 5 each; Figure 1A). In contrast,
IP-10 (100 nM) did not enhance eosinophil adhesion to
either VCAM-1 or fibronectin, which are counter
ligands for eosinophil a4 integrin, compared with con-
trols (46.8 ± 4.5% vs. 56.7 ± 4.6% and 20.4 ± 2.8% vs.
20.2 ± 1.8%, respectively; both NS; n = 5 each; Figure
1B and data not shown). We evaluated the effects of
incubation with IP-10 on the adhesiveness of eosinophils
to ICAM-1 over time. Eosinophils were incubated with
or without IP-10 (100 nM) for periods ranging from 5
to 60 min, washed, and then adhesion to ICAM-1 was
evaluated. The results showed that IP-10 (100 nM) aug-
mented eosinophil adhesiveness started from 20 min
and lasted for 60 min (P < 0.05 for all time points
between 20 and 60 min, n = 6; Figure 1C).
Effects of anti-integrin mAbs on eosinophil adhesion
enhanced by ICAM-1 and IP-10
To identify the eosinophil integrin(s) involved in IP-10-
induced eosinophil adhesion to ICAM-1, we incubated
eosinophils with anti-b2 integrin mAb, anti-a4 integrin
mAb, or an isotype-matched control mouse IgG1 at
ambient temperature for 15 min, and then evaluated
adhesion. Eosinophil adhesion that was enhanced by
ICAM-1 plus IP-10 was inhibited by anti-b2 integrin
mAb (mouse IgG1 vs. anti-b2 integrin mAb: 36.8 ± 3.2%
vs. 21.1 ± 2.7%, P < 0.01; n = 6 each; Figure 2A). Anti-
a4 integrin mAb did not modify the ICAM-1 and IP-10-
enhanced eosinophil adhesion (mouse IgG1 vs. anti-a4
integrin mAb: 36.8 ± 3.2% vs. 33.3 ± 3.2%, NS; n = 6
each; Figure 2A). Neither anti-a4 integrin mAb nor
anti-b2 integrin mAb modified spontaneous eosinophil
adhesion (Figure 2A).
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enhanced by ICAM-1 and IP-10
We examined whether CXCR3, a major receptor for CXC
chemokines, is involved in IP-10-induced eosinophil
adhesion to ICAM-1. Eosinophils were incubated with
either anti-CXCR3 mAb or an isotype-matched control
mouse IgG1 at ambient temperature for 15 min before
adhesion assays. Anti-CXCR3 mAb inhibited the eosino-
phil adhesion that was enhanced by ICAM-1 plus IP-10
(mouse IgG1 vs. anti-CXCR3 mAb: 28.5 ± 2.2 vs. 16.5 ±
1.2%; P < 0.001; n = 6; Figure 2B), suggesting that IP-10
could directly upregulate eosinophil adhesion via CXCR3.
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Figure 1 IP-10 significantly enhances the adhesiveness of eosinophils. (A) IP-10 significantly augments eosinophil adhesion to rh-ICAM-1-
coated plates. Eosinophils (100 μlo f1×1 0
5 cells/ml in HBSS/gel) obtained from different healthy donors, were incubated with IP-10 (10-100
nM) at 37°C for 20 min in rh-ICAM-1-coated plates. The adhesiveness of the eosinophils was then assessed by assay of residual EPO activity. Data
are shown as means ± SEM of 5 experiments using cells from different donors. (B) IP-10 does not modify eosinophil adhesion to rh-VCAM-1-
coated plates. Eosinophils were incubated with IP-10 (10-100 nM) in rh-VCAM-1-coated plates, and the adhesiveness of the eosinophils was
examined. Data are shown as means ± SEM of 5 experiments using cells from different donors. (C) Time course of IP-10 induction of eosinophil
adhesion to ICAM-1 coated plates. Eosinophils were incubated with or without IP-10 (100 nM) for periods ranging from 5 to 60 min. The kinetics
of eosinophil adhesion to ICAM-1 coated plates was determined by aspiration of non-adhered cells at the indicated times, followed by washing
every 5 min for the next 10 min and then every 10 min over the next 50 min, following which adhesion was assayed. Data are shown as means
± SEM of 6 experiments using cells from different donors. Open and filled bars, eosinophil adhesion without and with IP-10, respectively. *P <
0.05 versus without IP-10.
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Figure 2 Anti-b2 integrin mAb and anti-CXCR3 mAb suppress eosinophil adhesion enhanced by ICAM-1 and IP-10. (A) IP-10-enhanced
eosinophil adhesion to ICAM-1 is inhibited by anti-b2 integrin mAb. Eosinophils were pre-incubated with either anti-integrin mAb (3 μg/ml) or
control IgG for 15 min prior to analysis of adhesion in the presence or absence of IP-10. Data are shown as means ± SEM of 6 experiments
using cells from different donors. (B) IP-10-enhanced eosinophil adhesion to ICAM-1 is inhibited by anti-CXCR3 mAb. Eosinophils were pre-
incubated with either anti-CXCR3 mAb (3 μg/ml) or control IgG for 15 min prior to analysis of adhesion in the presence or absence of IP-10.
Data are shown as means ± SEM of six experiments using cells from different donors. Open and filled bars, eosinophil adhesion without and
with IP-10, respectively. **P < 0.01 versus without IP-10.
##P < 0.01,
###P < 0.001 versus mouse IgG1.
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- generation in the
presence of ICAM-1
We next examined whether IP-10 modifies O2
- genera-
tion of eosinophils in the presence of ICAM-1. IP-10
did not affect O2
- generation by eosinophils at a concen-
tration of 30 nM (Figure 3A). However, at a concentra-
tion of 100 nM, IP-10 significantly activated eosinophil
O2
- generation in wells coated with ICAM-1 compared
with controls (5.2 ± 1.8 vs. 8.5 ± 3.0 nmol/10
6 cells, P <
0 . 0 5 ;n=6 ;F i g u r e3 A ) ,a l t h o u g ht h ee f f e c to fI P - 1 0o n
eosinophil O2
- generation was of small magnitude.
Effect of anti-b2 integrin or anti-CXCR3 mAb on
eosinophil O2
- generation induced by a combination of
ICAM-1 and IP-10
We investigated whether b2integrin or CXCR3 is
involved in the enhanced eosinophil O2
- generation
induced by ICAM-1 plus IP-10, by assay of the effect of
pre-incubating eosinophils with anti-b2 integrin mAb,
anti-CXCR3 mAb, or an isotype-matched control mouse
IgG1 at ambient temperature for 15 min prior to analy-
sis. Eosinophil O2
- generation induced by the combina-
tion of ICAM-1 and IP-10 was blocked by both anti-b2
integrin and anti-CXCR3 mAbs compared with mouse
IgG1 (4.9 ± 0.9 vs. 0.5 ± 0.9 and 4.0 ± 0.9 vs. 1.0 ± 0.6
nmol/10
6 cells, respectively; n = 7 each; P <0 . 0 5f o r
both; Figures 3B and 3C). Neither anti-b2 integrin mAb
nor anti-CXCR3 mAb modified spontaneous O2
- gen-
eration by eosinophils.
Effects of other CXCR3 ligands on adhesion and O2
-
generation of eosinophils
We examined whether CXCR3 ligands other than IP-10
modify eosinophil adhesion and O2
- generation by sti-
mulation of eosinophils with IP-10, Mig or I-TAC in
the presence of ICAM-1. At a concentration of 100 nM,
all of these CXCR3 ligands enhanced eosinophil adhe-
sion to ICAM-1 versus control (IP-10, Mig and I-TAC:
26.8 ± 5.8%, 23.9 ± 5.2% and 23.2 ± 5.4% respectively
vs. 12.9 ± 2.1%; P < 0.01, P <0 . 0 5a n dP <0 . 0 5 ;n=5
each; Figure 4A). However, in contrast to IP-10, 30 nM
of Mig or I-TAC did not increase eosinophil adhesion
to ICAM-1 (Figures 4B and 4C), suggesting that the
effect of Mig or I-TAC on eosinophil adhesion was
weaker than that of IP-10. All of the CXCR3 ligands
augmented eosinophil O2
- generation in the presence of
ICAM-1 at a concentration of 100 nM, but not at a con-
centration of 30 nM (IP-10, Mig and I-TAC: 16.0 ± 1.7,
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Figure 3 IP-10 significantly enhances eosinophil O2
- generation. (A) IP-10 significantly enhances eosinophil O2
- generation in the presence
of ICAM-1. Eosinophil cell density was adjusted to 1.25 × 10
6 cells/ml of HBSS/gel mixed 4:1 with cytochrome C, and the eosinophil suspension
was then added to ICAM-1 coated 96-well plates. Immediately after adding IP-10 (30 or 100 nM), eosinophil O2
- generation was measured based
on the SOD-inhibitable reduction of cytochrome C. Data are shown as means ± SEM of 5 experiments using cells from different donors. (B)
Eosinophil O2
- generation induced by the combination of IP-10 + ICAM-1 is blocked by anti-b2 integrin mAb. Eosinophils were pre-incubated
with anti-b2 integrin mAb (3 μg/ml) or control IgG for 15 min prior to analysis of O2
- generation of eosinophils as in (A). Data are shown as
means ± SEM of 7 experiments using cells from different donors. (C) Eosinophil O2
- generation induced by a combination of IP-10 + ICAM-1 is
blocked by anti-CXCR3 mAb. Eosinophils were pre-incubated with anti-CXCR3 mAb (3 μg/ml) or control IgG for 15 min prior to analysis of O2
-
generation of eosinophils as in (A). Data are shown as means ± SEM of 7 experiments using cells from different donors. Open and filled bars,
eosinophil O2
- generation without and with IP-10, respectively. *P < 0.05 versus without IP-10.
#P < 0.05 versus mouse IgG1.
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nmol/10
6 cells; P <0 . 0 1 ,P <0 . 0 5a n dP <0 . 0 5 ;n=5
each; Figures 4D-F).
Effect of CXCR3 ligands on EDN release or cytokine/
chemokine production by eosinophils
We examined the effect of CXCR3 ligands on the degra-
nulation of eosinophils as well as the production of
cytokines and chemokines by eosinophils. Eosinophils
were incubated with CXCR3 ligands and eosinophil
degranulation was evaluated by measurement of the
concentration of eosinophil-derived neurotoxin (EDN)
in the supernatant. At a concentration of 100 nM, IP-
10, but not Mig or I-TAC, increased EDN release (IP-
10, Mig and I-TAC: 9.2 ± 2.9, 6.3 ± 1.5 and 6.5 ± 1.5,
respectively, vs. 5.8 ± 1.6 ng/ml; P < 0.05, NS and NS; n
= 6 each; Figure 5), suggesting that only IP-10 induced
the degranulation of eosinophils. IP-10 did not increase
EDN release at a concentration of 30 nM (data not
shown). We next measured the concentrations of cyto-
kines and chemokines in supernatant using a Bio-plex
assay. As shown in Table 1, IP-10 at a concentration of
100 nM significantly increased the production of several
cytokines/chemokines, including proinflammatory
cytokines and Th1/Th2 cytokines, by eosinophils.
Although Mig or I-TAC increased MIP-1b or IL-9
respectively at a concentration of 100 nM, almost every
cytokine/chemokine was not upregulated by stimulation
with Mig or I-TAC. To confirm the reliability of the
Bio-plex assay kits, we measured IL-6 and IL-8 concen-
trations by ELISA, and similar results were obtained
(data not shown).
Discussion
We found that IP-10, a CXCR3 ligand, augments eosi-
nophil adhesiveness. This effect occurred when the
counter-adhesion protein was ICAM-1, but not VCAM-
1. We also found that IP-10 activates eosinophil O2
-
generation in the presence of ICAM-1. Anti-b2 integrin
or anti-CXCR3 mAb inhibited the induction of eosino-
phil adhesion or O2
- generation in the presence of
ICAM-1, suggesting that the effect of CXCR3 ligands
involves eosinophil b2 integrin and CXCR3. The other
CXCR3 ligands, Mig and I-TAC, also significantly
enhanced eosinophil adhesion to ICAM-1 and induced
eosinophil O2
- generation in the presence of ICAM-1.
Furthermore, IP-10 increased the release of EDN and
the production of a number of cytokines and
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Figure 4 Other CXCR3 ligands also enhance eosinophil adhesion and eosinophil O2
- generation. (A-C) All tested CXCR3 ligands
significantly augmented eosinophil adhesion to ICAM-1-coated plates. Eosinophils were incubated with or without CXCR3 ligands for 20 min,
and adhesion of eosinophils was then examined. (A) All of the CXCR3 ligands (100 nM) augmented eosinophil adhesion to ICAM-1. (B) Dose-
response relationship between Mig and eosinophil adhesion. (C) Dose-response relationship between I-TAC and eosinophil adhesion. Data
shown are means ± SEM of 5 experiments using cells from different donors. (D-F) All tested CXCR3 ligands significantly induced eosinophil O2
-
generation in the presence of ICAM-1. Eosinophil O2
- generation was measured with or without CXCR3 ligands. (D) All of the CXCR3 ligands (100
nM) induced eosinophil O2
- generation. (E) Dose-response relationship between Mig and eosinophil O2
- generation. (F) Dose-response
relationship between I-TAC and eosinophil O2
- generation. Data shown are means ± SEM of 5 experiments using cells from different donors. *P
< 0.05, **P < 0.01 versus without CXCR3 ligands.
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CXCR3 ligands including IP-10 as activators of eosino-
phils through b2 integrin and CXCR3.
Although allergic airway inflammation is generally
considered to be a process that is mediated by the Th2-
type response, recent reports suggest that the Th1-type
response also plays an important role. For example, the
passive transfer of OVA-specific Th1 cells exacerbates
OVA-induced airway eosinophilia in a mouse model
[25]. Because IP-10 is originally generated by IFN-g, and
CXCR3 is predominantly expressed on Th1 cells [26],
IP-10 is thought to play an important role in the Th1-
mediated immune response. However, similar to Th1
cells, IP-10 itself can exacerbate Th2-mediated airway
inflammation. For example, IP-10 overexpression in the
lung of a mouse model of allergic airway inflammation
increases airway hyperreactivity, eosinophilia, and IL-4
levels [27]. Furthermore, IP-10 deletion attenuated Th2-
type allergic airway inflammation in a mouse model of
asthma [27]. These results demonstrated that the Th1-
type chemokine IP-10 rather enhances Th2-mediated
eosinophilic inflammation. The mechanism through
which IP-10 exacerbates Th2-mediated inflammation
remains obscure.
Most asthma exacerbation in a clinical setting is
induced by viral respiratory infections, in particular
those caused by the rhinovirus (RV) [5]. Although eosi-
n o p h i l s ,a sw e l la sn e u t r o p h ils, are increased in asth-
matic airways during or after viral infection [7-9], their
mechanisms of action have not been fully clarified.
Recent evidence suggests that IP-10 is involved in RV-
induced asthma exacerbation [16-18]. For example, RV
infection induces bronchial epithelial cells to produce
IP-10 in vitro and in vivo [16]. Monocytic cells also play
an important role as a major source of IP-10 during RV
infection [17,28]. Serum IP-10 concentrations are speci-
fically increased in RV-induced asthma [18]. Further-
more, increased levels of IP-10 correlate with clinical
disease severity during RV-induced exacerbation. These
d a t as u g g e s tt h a tI P - 1 0i sl i k e l yt op l a yar o l ei nt h e
pathogenesis of virus-induced asthma exacerbation.
Our results suggest that IP-10 induces eosinophil
adhesiveness to ICAM-1, but not to VCAM-1 (Figure
1). Anti-CXCR3 Ab inhibited the induction of eosino-
phil adhesion (Figure 2B). Jinquan et al. reported that
CXCR3 is expressed on eosinophils and that IP-10
induces chemotaxis [16]. Therefore, IP-10 could directly
upregulate eosinophil functions via CXCR3. Indeed, in
the present study, a combination of IP-10 and ICAM-1
activated eosinophil functions, such as O2
- generation
(Figure 3A). Furthermore, IP-10 induced eosinophil
degranulation (Figure 5) and the production of a num-
ber of cytokines/chemokines (Table 1). ICAM-1 is not
only an adhesion molecule that plays an important role
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Figure 5 IP-10, but not Mig or I-TAC, induces eosinophil
release of EDN. Eosinophils (1 × 10
6 cells/ml) in 96-well plates
were incubated for the 240-min required to measure O2
-
generation, immediately centrifuged and the concentration of EDN
in cell-free supernatants was then quantified using ELISA. Data
shown are means ± SEM of 6 experiments using cells from different
donors. *P < 0.05 versus without CXCR3 ligands.
Table 1 Production of cytokines and chemokines by
eosinophils stimulated with CXCR3 ligands.
Cytokine Control
(pg/ml)
IP-10
(pg/ml)
Mig
(pg/ml)
I-TAC
(pg/ml)
IL-1ra 1.8 ± 0.7 25.0 ± 2.1* 3.8 ± 1.3 3.9 ± 0.9
IL-1b 0.3 ± 0.1 6.5 ± 2.5* 2.6 ± 1.0 1.8 ± 0.9
IL-2 0.0 ± 0.0 2.0 ± 0.1* 0.1 ± 0.1 0.1 ± 0.0
IL-4 0.1 ± 0.0 1.1 ± 0.1* 0.1 ± 0.0 0.1 ± 0.0
IL-5 0.0 ± 0.0 0.3 ± 0.1* 0.0 ± 0.0 0.0 ± 0.0
IL-6 9.2 ± 4.9 80.5 ± 27.4* 40.5 ± 17.4 29.5 ± 14.8
IL-7 0.1 ± 0.0 0.9 ± 0.1* 0.2 ± 0.1 0.2 ± 0.0
IL-8 186.8 ± 89.8 404.7 ± 73.3* 315.3 ± 79.7 251.7 ± 76.5
IL-9 1.1 ± 0.2 4.4 ± 0.4* 1.8 ± 0.3 2.2 ± 0.3*
IL-10 0.7 ± 0.2 2.1 ± 0.4* 1.2 ± 0.4 1.7 ± 0.6
IL-12(p70) 0.3 ± 0.1 0.9 ± 0.1* 0.4 ± 0.1 0.3 ± 0.1
IL-13 1.1 ± 0.3 1.8 ± 0.2* 1.4 ± 0.2 1.4 ± 0.2
IL-15 0.2 ± 0.0 0.5 ± 0.1* 0.3 ± 0.1 0.3 ± 0.1
IL-17 0.8 ± 0.2 2.5 ± 0.7* 0.6 ± 0.2 0.7 ± 0.4
Eotaxin 1.7 ± 0.6 23.2 ± 0.5* 2.4 ± 1.1 2.4 ± 0.9
FGF 1.4 ± 0.5 5.6 ± 1.3* 1.1 ± 0.6 3.1 ± 1.1
G-CSF 0.2 ± 0.1 2.5 ± 0.4* 0.5 ± 0.2 0.3 ± 0.2
GM-CSF 0.8 ± 0.3 9.4 ± 1.0* 1.6 ± 0.4 1.7 ± 0.5
IFN-g 2.6 ± 0.6 107.0 ± 10.3* 5.4 ± 2.1 5.6 ± 2.0
MCP-1 32.6 ± 14.3 86.5 ± 28.7* 65.5 ± 24.6 53.5 ± 22.1
MIP-1a 6.4 ± 2.8 30.7 ± 10.4* 17.8 ± 8.9 14.5 ± 7.9
MIP-1b 93.7 ± 31.0 183.5 ± 19.1* 160.0 ± 24.5* 135.5 ± 25.7
PDGF 0.6 ± 0.3 2.2 ± 0.5* 0.4 ± 0.1 1.2 ± 0.3
RANTES 6.5 ± 0.9 20.3 ± 1.0* 7.8 ± 1.1 7.9 ± 1.0
TNF-a 4.0 ± 1.9 19.2 ± 4.5* 5.3 ± 3.3 2.7 ± 1.0
VEGF 7.8 ± 2.6 13.3 ± 2.5* 10.5 ± 3.3 10.4 ± 2.8
Eosinophils were incubated with CXCR3 ligands for 24 h, and the
concentrations of cytokines and chemokines in cell-free supernatants were
measured using Bio-plex assay kits. *P < 0.05 versus without CXCR3 ligands.
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Page 7 of 9in inflammatory cell recruitment, but is also a cellular
receptor for the majority (90%) of RVs [29]. Further-
more, RV infection increases ICAM-1 expression on
epithelial cells [30,31]. Therefore, it is likely that eosino-
phil adhesion to epithelial cells through ICAM-1 would
be enhanced during RV-induced asthma exacerbation.
Moreover, eosinophil adhesion to ICAM-1 could acti-
vate eosinophil functions [11-13]. Since both IP-10 and
ICAM-1 can be upregulated in RV-induced asthma
exacerbation as described above, our results indicate
that IP-10 interaction with ICAM-1 in the airway may
play an important role in the activation and infiltration
of eosinophils during RV-induced asthma exacerbation.
Not only CXCR3, but also other chemokine receptors
are expressed on eosinophils. To date, constitutive and/
or inducible expression of CCR1, CCR3, CXCR1,
CXCR2, CXCR3, and CXCR4 has been reported in
human eosinophils [15,32-34]. Of these receptors, high
levels of CCR3 are constitutively expressed on eosino-
phils [35]. The CCR3 ligand, eotaxin, is a potent che-
moattractant and activator of eosinophils, and thus the
eotaxin/CCR3 axis presumably plays an essential role in
the development of allergic inflammation. However,
recent evidence indicates that chemokine receptor
expression on eosinophils in peripheral blood differs
from that on eosinophils in bronchoalveolar lavage fluid
(BALF) [36-38], suggesting that chemokine receptors
other than CCR3 also play important roles in eosinophil
functions in the airway. For example, Liu et al. reported
that eosinophils in the airway express more CXCR3 and
less CCR3 than those in peripheral blood [36]. Katoh et
al. found higher ratios of CXCR3-expressing eosinophils
in BALF than in peripheral blood [37]. Nagase et al.
reported that less CCR3 is expressed by eosinophils in
BALF than in peripheral blood [38]. These findings sug-
gest that eosinophils in the airways express more
CXCR3 and less CCR3 than those in the peripheral cir-
culation. The present study demonstrated that IP-10
activated the functions of eosinophils from peripheral
blood. Therefore, CCR3 and CXCR3 might play similar
roles in the activation and infiltration of eosinophils in
the asthmatic airway. Since IP-10 is less sensitive to cor-
ticosteroid [18], we speculate that regulation of the
CXCR3 ligand/CXCR3 axis would be important for reg-
ulating eosinophilic airway inflammation under specific
conditions, such as viral infections.
In contrast to IP-10, the role of Mig or of I-TAC in
the pathogenesis of asthma has not been fully clarified.
Pillete et al. reported that segmental allergen challenge
in asthmatic individuals induced a significant increase in
IP-10, but not in Mig or I-TAC, in BALF [39]. Fulker-
son et al. reported that Mig inhibits eosinophil
responses to diverse stimuli [40], suggesting an immune
suppressive role of Mig in some circumstances. The
present study demonstrated that both Mig and I-TAC
upregulate eosinophil functions such as adhesion to rh-
ICAM-1 and O2
- generation (Figure 4). Moreover, Mig
and I-TAC-enhanced eosinophil adhesion and respira-
tory burst were suppressed by anti-CXCR3 Ab. These
results suggested that both Mig and I-TAC could
directly activate eosinophils through CXCR3. However,
n e i t h e rM i gn o rI - T A Cm o d i f i e dt h er e l e a s eo fE D Nb y
eosinophils, and their effect on eosinophil adhesion or
cytokine/chemokine production was weaker than that of
IP-10 (Figures 4 and 5, and Table 1). Therefore, Mig or
I-TAC might have lesser significance for the pathogen-
esis of eosinophilic airway inflammation than IP-10.
Conclusions
In conclusion, our results indicate that CXCR3 ligands
upregulate eosinophil functions such as adhesion and O2
-
generation through CXCR3 and b2 integrin. Furthermore,
IP-10 increased eosinophil release of EDN and eosinophil
production of a number of cytokines/chemokines. There-
fore, inhibition of the CXCR3 ligand/CXCR3 axis might
serve as a strategy to suppress eosinophilic airway inflam-
mation, especially in virus-induced asthma exacerbation.
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